ホーム › フォーラム一覧 › 「米国での投資」お役立ちフォーラム › CNBC「Mad Money」エピソードのまとめ › Mad Money: 2020年6月8日(月)の放送の要点
- このトピックは空です。
-
投稿者投稿
-
-
2020年6月8日 11:06 PM #4591
暮眞★潤 (Jun Kurema)
キーマスターCramer: These are the stocks that helped power the Nasdaq to a new record high during the pandemic (https://www.cnbc.com/2020/06/08/jim-cramer-on-why-the-nasdaq-hit-a-new-all-time-high-during-the-pandemic.html)
- Stocks that benefit from the reopening of the U.S. economy have recently been surging.
- But CNBC’s Jim Cramer said the all-time intraday high for the Nasdaq ’is “more representative of this market” than the reopening trades.
- The “Mad Money” host goes through 10 key stocks, including Facebook, Apple and Nvidia, that have helped power the tech-heavy index to a fresh record.
10 key stocks mentioned: Facebook (FB) Apple (APPL), Amazon (AMZN), Alphabet (GOOGL), Microsoft (MSFT), Tesla (TSLA), Nvidia (NVDA), Cisco (CSCO), Paypal (PYPL), Intel (INTC).
Executive Interview: CEO of Airstream maker says new people are seeing benefits of traveling by RV during pandemic (https://www.cnbc.com/2020/06/08/ceo-of-airstream-maker-more-people-see-benefits-of-rv-travel-during-pandemic.html)
- Thor Industries CEO Bob Martin told CNBC the coronavirus pandemic has helped highlight the benefits of using recreational vehicles to travel.
- “They look at this lifestyle as a way to self-isolate, a way to spend time with your family,” Martin said in an interview with CNBC’s Jim Cramer on “Mad Money.”
- Touting the convenience of traveling in an RV, Martin said, “You really only have to stop to get gas.”
Ticker: THO
Executive Interview: Sorrento Therapeutics CEO: Start of human trials for our coronavirus drug are ‘two to three months away’ (https://www.cnbc.com/video/2020/06/08/sorrento-therapeutics-ceo-start-human-trials-of-our-coronavirus-drug-are-two-to-three-months-away.html)
Sorrento Therapeutics CEO Henry Ji joined CNBC’s Jim Cramer on Monday to discuss the company’s progress on its efforts to develop a drug for Covid-19.
Ticker: SRNE
Cramer’s lightning round: Software maker Ping Identity is a buy (https://www.cnbc.com/2020/06/08/cramers-lightning-round-software-maker-ping-identity-is-a-buy.html)
- Ping Identity: Buy.
- Biohaven Pharmaceuticals: “Remember, I’m the spokesperson for the American Migraine Foundation, and I say, yes, [buy].”
- Lumentum Holdings Inc.: “I like Lumentum. I like the optical section. I think you’ve got a winner, a little speculative.”
- Zynga: “I’ve missed Zynga. Zynga’s had a run because I’m so focused on Take-Two Interactive, which I still am. TTWO. I think it’s a winner.”
- First Horizon National Corp.: “FHN is way too low. I don’t get this. The big banks are moving.”
- HSBC Holdings: “Yeah, it’s probably OK.”
Ticker: PING, BHVN, LITE, ZNGA, FHN, HSBC
本トピックに関する質問、コメントは親フォーラム「米国での投資」お役立ちフォーラムから新規トピックとしてご投稿ください。
-
-
投稿者投稿
- トピック「Mad Money: 2020年6月8日(月)の放送の要点」には新しい返信をつけることはできません。